Current Pain and Headache Reports

, Volume 5, Issue 2, pp 114–123

Complex regional pain syndromes

  • Ralf Baron
  • Gunnar Wasner
Article

Abstract

Complex regional pain syndromes (CRPS) (formerly reflex sympathetic dystrophy and causalgia) are neuropathic pain conditions that are initiated by an extremity trauma or peripheral nerve lesion. Clinical definition and scientific understanding of CRPS are still evolving; however, both the clinical picture and therapeutic options are significantly influenced by a dysfunction of the sympathetic nervous system. Recent investigations suggest functional central abnormalities and a peripheral inflammatory component in the pathophysiology of CRPS. Interdisciplinary treatment includes physical, pharmacologic, and invasive interventional therapy, as well as stimulation techniques.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Stanton-Hicks M, Jänig W, Hassenbusch S, et al.: Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995, 63:127–133.PubMedCrossRefGoogle Scholar
  2. 2.
    Merskey H, Bogduk N: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Terms. Seattle: IASP Press; 1995.Google Scholar
  3. 3.
    Sudeck P: Über die akute (trophoneurotische) Knochenatrophie nach Entzündungen und Traumen der Extremitäten. Deut Med Wschr 1902, 28:336–342.CrossRefGoogle Scholar
  4. 4.
    Veldman PHJM: Clinical aspects of reflex sympathetic dystrophy [PhD thesis].Nijmegan, The Netherlands: The University of Nijmegen; 1995.Google Scholar
  5. 5.
    Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48:332–338.PubMedGoogle Scholar
  6. 6.
    Price DD, Bennett GJ, Rafii A: Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989, 36:273–288.PubMedCrossRefGoogle Scholar
  7. 7.
    Price DD, Long S, Huitt C: Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 1992, 49:163–173.PubMedCrossRefGoogle Scholar
  8. 8.
    Sieweke N, Birklein F, Riedl B, et al.: Patterns of hyperalgesia in complex regional pain syndrome. Pain 1999, 80:171–177.PubMedCrossRefGoogle Scholar
  9. 9.
    Rommel O, Gehling M, Dertwinkel R, et al.: Hemisensory impairment in patients with complex regional pain syndrome. Pain 1999, 80:95–101. Demonstrates that hemisensory deficits develop in CRPS. This is evidence for central disturbances in CRPS.PubMedCrossRefGoogle Scholar
  10. 10.
    Chelimsky TC, Low PA, Naessens JM, et al.: Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc 1995, 70:1029–1040.PubMedGoogle Scholar
  11. 11.
    Baron R, Maier C: Reflex sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy. Pain 1996, 67:317–326.PubMedCrossRefGoogle Scholar
  12. 12.
    Baron R, Blumberg H, Jänig W: Clinical characteristics of patients with complex regional pain syndromes in Germany with special emphasis on vasomotor function. In Progress in Pain Research and Management. Reflex Sympathetic Dystrophy—A Reappraisal, vol 6. Edited by Jänig W, Stanton-Hicks M. Seattle: IASP Press; 1996.Google Scholar
  13. 13.
    Birklein F, Riedl B, Neundörfer B, et al.: Sympathetic vasoconstrictor reflex pattern in patients with complex regional pain syndrome. Pain 1998, 75:93–100.PubMedCrossRefGoogle Scholar
  14. 14.
    Wasner G, Heckmann K, Maier C, et al.: Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I)—complete inhibition of sympathetic nerve activity with recovery. Arch Neurol 1999, 56:613–620. Describes a patient with acute CRPS and decreased cutaneous sympathetic vasoconstrictor activity in the affected limb. Further evidence for inhibited rather than enhanced sympathetic activity in acute CRPS is discussed.PubMedCrossRefGoogle Scholar
  15. 15.
    Wasner G, Backonja MM, Baron R: Traumatic neuralgias: complex regional pain syndromes (reflex sympathetic dystrophy and causalgia): clinical characteristics, pathophysiological mechanisms and therapy. Neurol Clin 1998, 16:851–868.PubMedCrossRefGoogle Scholar
  16. 16.
    Low PA, Amadio PC, Wilson PR, et al.: Laboratory findings in reflex sympathetic dystrophy: a preliminary report. Clin J Pain 1994, 10:235–239.PubMedCrossRefGoogle Scholar
  17. 17.
    Birklein F, Sittle R, Spitzer A, et al.: Sudomotor function in sympathetic reflex dystrophy. Pain 1997, 69:49–54.PubMedCrossRefGoogle Scholar
  18. 18.
    Blumberg H, Jänig W: Clinical manifestation of reflex sympathetic dystrophy and sympathetically maintained pain. In Textbook of Pain. Edited by Wall PD, Melzack R. London: Churchill Livingstone; 1994:685–697.Google Scholar
  19. 19.
    Deuschl G, Blumberg H, Lücking CH: Tremor in reflex sympathetic dystrophy. Arch Neurol 1991, 48:1247–1252.PubMedGoogle Scholar
  20. 20.
    Bhatia KP, Bhatt MH, Marsden CD: The causalgia-dystonia syndrome. Brain 1993, 116:843–851.PubMedCrossRefGoogle Scholar
  21. 21.
    Marsden CD, Obeso JA, Traub MM, et al.: Muscle spasms associated with Sudeck’s atrophy after injury. Br Med J 1984, 288:173–176.Google Scholar
  22. 22.
    Mitchell SW: Injuries of Nerves and Their Consequences. New York: Dover; 1865.Google Scholar
  23. 23.
    Leriche R: De la causalgie envisagée comme une névrite du sympathique et de son traitement par la dénudation et l’excision des plexus nerveux péri-artériels. Presse Med 1916, 24:178–180.Google Scholar
  24. 24.
    Richards RL: Causalgia. A centennial review. Arch Neurol 1967, 16:339–350.PubMedGoogle Scholar
  25. 25.
    Baron R, Jänig W: Pain syndromes with causal participation of the sympathetic nervous system. Anaesthesist 1998, 47:4–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Galer BS, Bruehl S, Harden RN: IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain. Clin J Pain 1998, 14:48–54.PubMedCrossRefGoogle Scholar
  27. 27.
    Bruehl S, Harden RN, Galer BS, et al.: External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999, 81:147–154.PubMedCrossRefGoogle Scholar
  28. 28.
    Fleming WW, Westfall DP: Adaptive supersensitivity. In Handbook of Experimental Pharmacology. Edited by Trendelenburg U, Weiner N. New York: Springer Verlag; 1988:509–559.Google Scholar
  29. 29.
    Kurvers HA, Tangelder GJ, De Mey JG, et al.: Skin blood flow abnormalities in a rat model of neuropathic pain: result of decreased sympathetic vasoconstrictor outflow? J Auton Nerv Syst 1997, 63:19–29.PubMedCrossRefGoogle Scholar
  30. 30.
    Wakisaka S, Kajander KC, Bennett GJ: Abnormal skin temperature and abnormal sympathetic vasomotor innervation in an experimental painful peripheral neuropathy. Pain 1991, 46:299–313.PubMedCrossRefGoogle Scholar
  31. 31.
    Goldstein DS, Tack C, Li ST: Sympathetic innervation and function in reflex sympathetic dystrophy. Ann Neurol 2000, 48:49–59.PubMedCrossRefGoogle Scholar
  32. 32.
    Wasner G, Schattschneider J, Heckmann K, et al.: Vascular abnormalities in reflex sympathetic dystrophy (CRPS I)—mechanisms and diagnostic value. Brain 2000, in press.Google Scholar
  33. 33.
    Drummond PD, Finch PM, Smythe GA: Reflex sympathetic dystrophy: the significance of differing plasma catecholamine concentrations in affected and unaffected limbs. Brain 1991, 114:2025–2036.PubMedCrossRefGoogle Scholar
  34. 34.
    Harden RN, Duc TA, Williams TR, et al.: Norepinephrine and epinephrine levels in affected versus unaffected limbs in sympathetically maintained pain. Clin J Pain 1994, 10:324–330.PubMedCrossRefGoogle Scholar
  35. 35.
    Blumberg H, Jänig W: Reflex patterns in postganglionic vasoconstrictor neurons following chronic nerve lesions. J Auton Nerv Syst 1985, 14:157–180.PubMedCrossRefGoogle Scholar
  36. 36.
    Jänig W, Koltzenburg M: Sympathetic reflex activity and neuroeffector transmission change after chronic nerve lesions. In Proceedings of the VIth World Congress on Pain. Edited by Bond MR et al. Amsterdam: Elsevier Science Puplishers BV; 1991:365–371.Google Scholar
  37. 37.
    Casale R, Elam M: Normal sympathetic nerve activity in a reflex sympathetic dystrophy with marked skin vasoconstriction. J Auton Nerv Syst 1992, 41:215–219.PubMedCrossRefGoogle Scholar
  38. 38.
    Torebjörk E: Clinical and neurophysiological observations relating to pathophysiological mechanisms of reflex sympathetic dystrophy. In Reflex Sympathetic Dystrophy. Edited by Stanton-Hicks M et al. Boston: Kluwer; 1989:971–980.Google Scholar
  39. 39.
    Jänig W, McLachlan EM: Neurobiology of the autonomic nervous system. In Autonomic Failure. Edited by Bannister R, Mathias CM. Oxford: Oxford University Press; 1994.Google Scholar
  40. 40.
    Drummond PD, Skipworth S, Finch PM: Alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci (Colch) 1996, 91:73–77.Google Scholar
  41. 41.
    Arnold JM, Teasell RW, MacLeod AP, et al.: Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med 1993, 118:619–621.PubMedGoogle Scholar
  42. 42.
    Leitha T, Korpan M, Staudenherz A, et al.: Five phase bone scintigraphy supports the pathophysiological concept of a subclinical inflammatory process in reflex sympathetic dystrophy. Q J Nucl Med 1996, 40:188–193.PubMedGoogle Scholar
  43. 43.
    Weber M, Neundörfer B, Birklein F: Funktion primärer Afferenzen bei komplexem regionalen Schmerzsyndrom. Akt Neurol 2000, 27:S101.Google Scholar
  44. 44.
    Calder JS, Holten I, McAllister RM: Evidence for immune system involvement in reflex sympathetic dystrophy. J Hand Surg [Br] 1998, 23:147–150.CrossRefGoogle Scholar
  45. 45.
    van der Laan L, Goris RJ: Reflex sympathetic dystrophy. An exaggerated regional inflammatory response? Hand Clin 1997, 13:373–385.PubMedGoogle Scholar
  46. 46.
    Christensen K, Jensen EM, Noer I: The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand 1982, 148:653–655.PubMedGoogle Scholar
  47. 47.
    Oyen WJ, Arntz IE, Claessens RM, et al.: Reflex sympathetic dystrophy of the hand: an excessive inflammatory response? Pain 1993, 55:151–157.PubMedCrossRefGoogle Scholar
  48. 48.
    Renier JC, Arlet J, Bregeon C, et al.: The joint in algodystrophy. Joint fluid, synovium, cartilage. Rev Rhum Mal Osteoartic 1983, 50:255–260.PubMedGoogle Scholar
  49. 49.
    Kozin F, McCarty DJ, Sims J, et al.: The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. Am J Med 1976, 60:321–331.PubMedCrossRefGoogle Scholar
  50. 50.
    Hannington-Kiff JG: Relief of Sudeck’s atrophy by regional intravenous guanethidine. Lancet 1977, 1:1132–1133.PubMedCrossRefGoogle Scholar
  51. 51.
    Levine JD, Taiwo YO, Collins SD, et al.: Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 1986, 323:158–160.PubMedCrossRefGoogle Scholar
  52. 52.
    Perl ER: Cutaneous polymodal receptors: characteristics and plasticity. Prog Brain Res 1996, 113:21–37.PubMedGoogle Scholar
  53. 53.
    Levine JD, Fye K, Heller P, et al.: Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J Rheumatol 1986, 13:1040–1043.PubMedGoogle Scholar
  54. 54.
    Arnér S: Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy. Pain 1991, 46:17–22.PubMedCrossRefGoogle Scholar
  55. 55.
    Raja SN, Treede RD, Davis KD, et al.: Systemic alphaadrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 1991, 74:691–698.PubMedCrossRefGoogle Scholar
  56. 56.
    Baron R, Wasner G, Borgstedt R, et al.: Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation. Neurology 1999, 52:923–932. Demonstrates that physiologic sympathetic activity does not influence experimental pain. Under physiologic conditions there seems to be no interaction between sympathetic efferents and nociceptive afferents.PubMedGoogle Scholar
  57. 57.
    Elam M, Olausson B, Skarphedinsson JO, et al.: Does sympathetic nerve discharge affect the firing of polymodal C-fibre afferents in humans? Brain 1999, 122:2237–2244.PubMedCrossRefGoogle Scholar
  58. 58.
    Jänig W, Levine JD, Michaelis M: Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 1996, 113:161–184.PubMedCrossRefGoogle Scholar
  59. 59.
    Shi T-JS, Winzer-Serhan U, Leslie F, Hökfeldt T: Distribution and regulation of alpha-2 adrenoceptors in rat dorsal root ganglia. Pain 2000, 84:319–330.PubMedCrossRefGoogle Scholar
  60. 60.
    Chabal C, Jacobson L, Russell LC, et al.: Pain response to perineuromal injection of normal saline, epinephrine, and lidocaine in humans. Pain 1992, 49:9–12.PubMedCrossRefGoogle Scholar
  61. 61.
    Raja SN, Abatzis V, Frank SM: Role of α-adrenoceptors in neuroma pain in amputees [abstract]. Anesthesiology 1998, 89:A1083.CrossRefGoogle Scholar
  62. 62.
    Walker AE, Nulsen F: Electrical stimulation of the upper thoracic portion of the sympathetic chain in man. Arch Neurol Psychiatr 1948, 59:559–560.Google Scholar
  63. 63.
    White JC, Sweet WH: Pain and the Neurosurgeon: A Forty-Year Experience. Edited by Thomas CC. Springfield, Illinois: CC Thomas; 1969.Google Scholar
  64. 64.
    Torebjörk E, Wahren L, Wallin G, et al.: Noradrenaline-evoked pain in neuralgia. Pain 1995, 63:11–20.PubMedCrossRefGoogle Scholar
  65. 65.
    Choi B, Rowbotham MC: Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain 1997, 69:55–63.PubMedCrossRefGoogle Scholar
  66. 66.
    Ali Z, Raja SN, Wesselmann U, et al.: Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000, 88:161–168.PubMedCrossRefGoogle Scholar
  67. 67.
    Green PG, Janig W, Levine JD: Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci 1997, 17:3234–3238.PubMedGoogle Scholar
  68. 68.
    Kingery WS: A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997, 73:123–139.PubMedCrossRefGoogle Scholar
  69. 69.
    Schott GD: Visceral afferents: their contribution to "fsympathetic dependent" pain. Brain 1994, 117:397–413.PubMedCrossRefGoogle Scholar
  70. 70.
    Verdugo RJ, Ochoa JL: "Sympathetically maintained pain." I. Phentolamine block questions the concept. Neurology 1994, 44:1003–1010.PubMedGoogle Scholar
  71. 71.
    Price DD, Long S, Wilsey B, et al.: Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional syndrome patients. Clin J Pain 1998, 14:216–226. Shows the pain-relieving effects of lidocaine and saline block of sympathetic ganglia. Both induced a significant pain reduction in the first hours after the block, but only lidocaine had a prolonged effect.PubMedCrossRefGoogle Scholar
  72. 72.
    Bonelli S, Conoscente F, Movilia PG, et al.: Regional intravenous guanethidine vs. stellate ganglion block in reflex sympathetic dystrophies: a randomized trial. Pain 1983, 16:297–307.PubMedCrossRefGoogle Scholar
  73. 73.
    Glynn CJ, Basedow RW, Walsh JA: Pain relief following post-ganglionic sympathetic blockade with I.V. guanethidine. Br J Anaesth 1981, 53:1297–1302.PubMedGoogle Scholar
  74. 74.
    Rocco AG, Kaul AF, Reisman RM, et al.: A comparison of regional intravenous guanethidine and reserpine in reflex sympathetic dystrophy. A controlled, randomized, double-blind crossover study. Clin J Pain 1989, 5:205–209.PubMedCrossRefGoogle Scholar
  75. 75.
    Jadad AR, Carroll D, Glynn CJ, et al.: Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study. J Pain Symptom Manage 1995, 10:13–20.PubMedCrossRefGoogle Scholar
  76. 76.
    Blanchard J, Ramamurthy S, Walsh N, et al.: Intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine, and normal saline. J Pain Symptom Manage 1990, 5:357–361.PubMedCrossRefGoogle Scholar
  77. 77.
    Ramamurthy S, Hoffman J: Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Guanethidine Study Group. Anesth Analg 1995, 81:718–723.PubMedCrossRefGoogle Scholar
  78. 78.
    Loh L, Nathan PW: Painful peripheral states and sympathetic blocks. J Neurol Neurosurg Psychiatry 1978, 41:664–671.PubMedCrossRefGoogle Scholar
  79. 79.
    Hord AH, Rooks MD, Stephens BO, et al.: Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy: a randomized, double-blind study. Anesth Analg 1992, 74:818–821.PubMedCrossRefGoogle Scholar
  80. 80.
    Spacek A, Bohm D, Kress HG: Ganglionic local opioid analgesia for refractory trigeminal neuralgia [letter]. Lancet 1997, 349:1521.PubMedCrossRefGoogle Scholar
  81. 81.
    Maier C: Ganglionäre Lokale Opioidanalgesie (GLOA—Ein Neues Therapieverfahren bei persistierenden Neuropathischen Schmerzen. Stuttgart: Thieme; 1996.Google Scholar
  82. 82.
    Kozin F, Soin JS, Ryan LM, et al.: Bone scintigraphy in the reflex sympathetic dystrophy syndrome. Radiology 1981, 138:437–443.PubMedGoogle Scholar
  83. 83.
    Zyluk A: The usefulness of quantitative evaluation of three-phase scintigraphy in the diagnosis of posttraumatic reflex sympathetic dystrophy. J Hand Surg [Br] 1999, 24:16–21. Deals with the three-phase scintigraphy as a diagnostic tool in CRPS. Validity of the method is discussed.CrossRefGoogle Scholar
  84. 84.
    Wahren LK, Torebjork E, Nystrom B: Quantitative sensory testing before and after regional guanethidine block in patients with neuralgia in the hand. Pain 1991, 46:23–30.PubMedCrossRefGoogle Scholar
  85. 85.
    Wahren LK, Torebjork E: Quantitative sensory tests in patients with neuralgia 11 to 25 years after injury. Pain 1992, 48:237–244.PubMedCrossRefGoogle Scholar
  86. 86.
    Birklein F, Riedl B, Sieweke N, et al.: Neurological findings in complex regional pain syndromes—analysis of 145 cases. Acta Neurol Scand 2000, 101:262–269.PubMedCrossRefGoogle Scholar
  87. 87.
    Schürmann M, Gradl G, Andress HJ, et al.: Assessment of peripheral sympathetic nervous function for diagnosing early post-traumatic complex regional pain syndrome type I. Pain 1999, 80:149–159.PubMedCrossRefGoogle Scholar
  88. 88.
    Bruehl S, Lubenow TR, Nath H, et al.: Validation of thermography in the diagnosis of reflex sympathetic dystrophy. Clin J Pain 1996, 12:316–325.PubMedCrossRefGoogle Scholar
  89. 89.
    Gulevich SJ, Conwell TD, Lane J, et al.: Stress infrared telethermography is useful in the diagnosis of complex regional pain syndrome, type I (formerly reflex sympathetic dystrophy). Clin J Pain 1997, 13:50–59.PubMedCrossRefGoogle Scholar
  90. 90.
    Tanelian DT: Reflex sympathetic dystrophy: a reevaluation of the literature. Pain Forum 1996, 5:247–256.Google Scholar
  91. 91.
    Rowbotham MC, Reisner-Keller LA, Fields HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991, 41:1024–1028.PubMedGoogle Scholar
  92. 92.
    Watson CP, Evans RJ, Reed K, et al.: Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982, 32:671–673.PubMedGoogle Scholar
  93. 93.
    Max MB: Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994, 35(suppl):S50-S53.PubMedCrossRefGoogle Scholar
  94. 94.
    Max MB, Lynch SA, Muir J, et al.: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992, 326:1250–1256.PubMedCrossRefGoogle Scholar
  95. 95.
    Watson CP, Evans RJ: A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985, 23:387–394.PubMedCrossRefGoogle Scholar
  96. 96.
    Kishore-Kumar R, Schafer SC, Lawlor BA, et al.: Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain 1989, 37:223–227.PubMedCrossRefGoogle Scholar
  97. 97.
    Dejgard A, Petersen P, Kastrup J: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988, 1:9–11.PubMedCrossRefGoogle Scholar
  98. 98.
    van Hilten BJ, van de Beek WJ, Hoff JI, et al.: Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 2000, 343:625–630. Illuminated intrathecal baclofen as a new treatment option in patients with CRPS with dystonia. A double-blind, randomized, controlled crossover trial with three different doses of baclofen and placebo was performed on seven women. In six patients baclofen was helpful at least partially.PubMedCrossRefGoogle Scholar
  99. 99.
    Mellick GA, Mellicy LB, Mellick LB: Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995, 10:265–266.PubMedCrossRefGoogle Scholar
  100. 100.
    Davis KD, Treede RD, Raja SN, et al.: Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991, 47:309–317.PubMedCrossRefGoogle Scholar
  101. 101.
    Byas-Smith MG, Max MB, Muir J, et al.: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage "enriched enrollment" design. Pain 1995, 60:267–274.PubMedCrossRefGoogle Scholar
  102. 102.
    Sherry DD, Wallace CA, Kelley C, et al.: Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy. Clin J Pain 1999, 15:218–223.PubMedCrossRefGoogle Scholar
  103. 103.
    Oerlemans HM, Oostendorp RA, de Boo T, et al.: Pain and reduced mobility in complex regional pain syndrome I: outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy. Pain 1999, 83:77–83. Investigates the effect of adjuvant physical therapy and occupational therapy in CRPS. The results indicated that physical therapy, and to a lesser extent occupational therapy, were helpful for reducing pain and improving active mobility in patients with CRPS I of less than 1-year duration, localized in one upper extremity.PubMedCrossRefGoogle Scholar
  104. 104.
    Hassenbusch SJ, Stanton-Hicks M, Schoppa D, et al.: Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg 1996, 84:415–423.PubMedCrossRefGoogle Scholar
  105. 105.
    Kemler MA, Barendse GA, van Kleef M, et al.: Pain relief in complex regional pain syndrome due to spinal cord stimulation does not depend on vasodilation. Anesthesiology 2000, 92:1653–1660.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Ralf Baron
    • 1
  • Gunnar Wasner
    • 1
  1. 1.Klinik für NeurologieChristian-Albrechts-Universität KielKielGermany

Personalised recommendations